Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial
Abstract Background Activation of the transforming growth factor beta (TGF-β) pathway is a significant contributor to the pathogenesis of diabetic nephropathy. Carnosine is a dipeptide that can inhibit TGF-β synthesis. We tested the hypothesis that carnosine supplement added to standard therapy will...
Main Authors: | Narongrit Siriwattanasit, Bancha Satirapoj, Ouppatham Supasyndh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12882-021-02434-7 |
Similar Items
-
Carnosine Prevents Aβ-Induced Oxidative Stress and Inflammation in Microglial Cells: A Key Role of TGF-β1
by: Giuseppe Caruso, et al.
Published: (2019-01-01) -
Responses to β-alanine and carnosine supplementation of mussel Mytilus coruscus as revealed by UPLC–MS/MS based untargeted metabolomics
by: Chun-yue Wang, et al.
Published: (2021-07-01) -
Cystatin-C and TGF-β levels in patients with diabetic nephropathy
by: Mumtaz Takir, et al.
Published: (2016-11-01) -
Cystatin-C and TGF-β levels in patients with diabetic nephropathy
by: Mumtaz Takir, et al.
Published: (2016-11-01) -
Chrysophanol Inhibits the Progression of Diabetic Nephropathy via Inactivation of TGF-β Pathway
by: Guo C, et al.
Published: (2020-11-01)